miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Fangfang,Tao ^[1] ; Xinxin,Tian ^[2] ; Shanming,Ruan ^[3] ; Minhe,Shen ^[4] ; Zhiqian,Zhang ^[4]

作者单位： Department of Immunology and Microbiology, Basic Medical College, Zhejiang Chinese Medical University, Hangzhou, China. ^[1] Department of Biochemistry and Biophysics, Texas A&M AgriLife Research, Texas A&M University, College Station, Texas, USA. ^[2] Tianjin International Joint Academy of Biomedicine (TJAB), Tianjin, China. ^[3] Department of Medical Oncology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China. ^[4] State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China. ^[5]

关键词 MALAT1 MiR-211 PHF19 ceRNA ovarian cancer

DOI 10.1096/fj.201800495RR

PMID 29874124

发布时间 2024-02-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览40

FASEB journal

fj201800495RR页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma.

FASEB journal

相似文献

FASEB journal

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma.

FASEB journal

相似文献

FASEB journal

相关期刊

检索历史清除